Clinical Trials in Nashville

Showing 5061-5080 of 15,379 trials

REmodeling the Left Ventricle With Atrial Modulated Pacing

NCT03210402

New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure22 participantsStarted Sep 2017

Tucson, Arizona, United States • Stockton, California, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

NCT03686683

The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-metastatic prostate cancer compared to participants followed on active surveillance as standard of care.

Adenocarcinoma of the Prostate

Dendreon532 participantsStarted Oct 2018

Gilbert, Arizona, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +53 more locations

REmodeling the Left Ventricle With Atrial Modulated Pacing

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Find Trials by Condition in Nashville

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

The MOTION Study - Treatment of LSS With the MILD Procedure

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Wearable Assessments in the Clinic and Home in PD

Observational Study of Obstructive Lung Disease (NOVELTY)

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

WHOOP ECG Software Performance Assessment Study

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force